Surrozen, Inc./DE SEC filings SRZN
Surrozen, Inc./DE has 496 filings in SEC EDGAR's recent list, going back to Sep 18, 2020. Its latest annual report, Form ARS, was filed on Apr 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 20, 2026 (results of operations, unregistered share sale). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Mar 30, 2026 | — |
| S-8 | Employee stock plan registration | Mar 23, 2026 | — |
| S-3 | Shelf registration | Mar 23, 2026 | — |
| 424B5 | Prospectus supplement | Aug 29, 2025 | — |
| S-8 | Employee stock plan registration | Aug 8, 2025 | — |
| S-3 | Shelf registration | May 20, 2025 | — |
| 424B5 | Prospectus supplement | May 1, 2025 | — |
| 424B5 | Prospectus supplement | Apr 24, 2025 | — |
| S-3 | Shelf registration | Apr 23, 2025 | — |
| S-8 | Employee stock plan registration | Mar 31, 2025 | — |
| 424B5 | Prospectus supplement | Apr 25, 2024 | — |
| S-3 | Shelf registration | Apr 18, 2024 | — |
| S-8 | Employee stock plan registration | Apr 10, 2024 | — |
| 424B3 | Prospectus | Feb 7, 2024 | — |
| 424B3 | Prospectus | Jan 22, 2024 | — |
| 424B3 | Prospectus | Dec 13, 2023 | — |
| 424B3 | Prospectus | Dec 11, 2023 | — |
| 424B3 | Prospectus | Nov 8, 2023 | — |
| 424B3 | Prospectus | Aug 9, 2023 | — |
| 424B3 | Prospectus | May 10, 2023 | — |
| 424B3 | Prospectus | Apr 7, 2023 | — |
| 424B3 | Prospectus | Apr 7, 2023 | — |
| 424B3 | Prospectus | Apr 6, 2023 | — |
| POS AM | Filing | Mar 31, 2023 | — |
| 424B5 | Prospectus supplement | Mar 31, 2023 | — |
| POS AM | Filing | Mar 31, 2023 | — |
| S-8 | Employee stock plan registration | Mar 31, 2023 | — |
| 424B3 | Prospectus | Mar 23, 2023 | — |
| 424B3 | Prospectus | Mar 23, 2023 | — |
| 424B3 | Prospectus | Jan 5, 2023 | — |
| 424B3 | Prospectus | Jan 5, 2023 | — |
| 424B5 | Prospectus supplement | Dec 21, 2022 | — |
| 424B3 | Prospectus | Dec 15, 2022 | — |
| 424B3 | Prospectus | Dec 15, 2022 | — |
| S-3 | Shelf registration | Dec 9, 2022 | — |
| 424B3 | Prospectus | Nov 15, 2022 | — |
| 424B3 | Prospectus | Nov 15, 2022 | — |
| 424B3 | Prospectus | Aug 25, 2022 | — |
| 424B3 | Prospectus | Aug 23, 2022 | — |
| 424B3 | Prospectus | May 12, 2022 | — |
| 424B3 | Prospectus | May 12, 2022 | — |
| 424B3 | Prospectus | Apr 5, 2022 | — |
| 424B3 | Prospectus | Mar 31, 2022 | — |
| S-8 | Employee stock plan registration | Mar 29, 2022 | — |
| S-1 | Registration statement | Mar 29, 2022 | — |
| POS AM | Filing | Mar 29, 2022 | — |
| 424B3 | Prospectus | Feb 24, 2022 | — |
| 424B3 | Prospectus | Jan 10, 2022 | — |
| 424B3 | Prospectus | Nov 16, 2021 | — |
| 424B3 | Prospectus | Nov 10, 2021 | — |
| S-1/A | Amended registration statement | Nov 8, 2021 | — |
| S-8 | Employee stock plan registration | Nov 8, 2021 | — |
| S-1 | Registration statement | Sep 13, 2021 | — |
| 424B3 | Prospectus | Jul 15, 2021 | — |
| S-4/A | Filing | Jul 13, 2021 | — |
| S-4/A | Filing | Jun 24, 2021 | — |
| S-4 | Registration for a merger or exchange | May 14, 2021 | — |
| 424B4 | Prospectus | Nov 19, 2020 | — |
| S-1/A | Amended registration statement | Nov 12, 2020 | — |
| S-1/A | Amended registration statement | Nov 6, 2020 | — |
| S-1/A | Amended registration statement | Oct 27, 2020 | — |
| S-1/A | Amended registration statement | Oct 26, 2020 | — |
| S-1/A | Amended registration statement | Oct 13, 2020 | — |
| S-1 | Registration statement | Oct 9, 2020 | — |
Showing 64 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- SRZN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- South San Francisco, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1824893
- Former names
- Consonance-HFW Acquisition Corp. (until Aug 11, 2021)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.